Day 1 - Afternoon

Group 2A: HER2+ Breast Cancer; Biomarkers; Real-World Data/Outcomes; Tumor Biology Last Few Tickets

Group 2B: Lobular Breast Cancer Sold Out

Group 2C: Breast Cancer; Biomarkers; Tumor Biology Sold Out

Group 2D: Breast Cancer; Clinical Trials; Symptoms & Survivorship

Group 2E: Breast & Pan-Cancers; Symptoms & Survivorship; Underserved Populations

Group 2F: HR+ Breast Cancer; Clinical Trials; Novel Targets & Therapies; Treatment Resistance Sold Out

Group 2G: Pan-Cancers; Clinical Trials; Symptoms & Survivorship